| HOME >> BIOLOGY >> TECHNOLOGY |
Total operating expenses 13,579 15,466 55,216 53,330
Loss from operations (6,994) (10,025) (24,541) (31,436)
Other income (expense):
Interest and other income 753 991 3,545 3,832
Interest expense (475) (717) (2,625) (3,436)
Debt conversion expense (495) - (718) (2,287)
Net other income (expense) (217) 274 202 (1,891)
Net loss $(7,211) $(9,751) $(24,339) $(33,327)
Net loss per share, basic and
diluted $(0.10) $(0.14) $(0.35) $(0.51)
Shares used in computing basic and
diluted net loss per share 73,641 68,980 70,483 65,961
(1) Includes stock-based
compensation related to the
following:
Cost of revenues $32 $28 $130 $75
Research and development 995 801 4,286 2,885
Selling, general and administrative 553 420 2,273 1,431
Total stock-based compensation $1,580 $1,249 $6,689 $4,391
DURECT CORPORATION
Condensed Balance Sheet
(in thousands)
As of As of
December 31, December 31,
2007 2006 (1)
(unaudited)
ASSETS
Current assets:
Cash and cash equivalents $37,589 $41,554
Short-term investments 19,710 28,297
Accounts receivable 3,622 2,152
Inventories
'/>"/>
| SOURCE DURECT Corporation Copyright©2008 PR Newswire. All rights reserved |